DSGN
Design Therapeutics Inc

376
Mkt Cap
$369.59M
Volume
50,789.00
52W High
$7.77
52W Low
$2.60
PE Ratio
-5.80
DSGN Fundamentals
Price
$6.57
Prev Close
$6.49
Open
$6.61
50D MA
$6.12
Beta
1.57
Avg. Volume
189,279.90
EPS (Annual)
-$0.8763
P/B
1.73
Rev/Employee
$0.00
Loading...
Loading...
Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
54

Frequently Asked Questions

What is Market Cap of Design Therapeutics Inc?
What is the 52-week high for Design Therapeutics Inc?
What is the 52-week low for Design Therapeutics Inc?
What is Design Therapeutics Inc stock price today?
What was Design Therapeutics Inc stock price yesterday?
What is the PE ratio of Design Therapeutics Inc?
What is the Price-to-Book ratio of Design Therapeutics Inc?
What is the 50-day moving average of Design Therapeutics Inc?
How many employess does Design Therapeutics Inc has?

Latest DSGN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.